The Patent Finder
US

Method and Composition for Treating Arginase 1 Deficiency

US 11,717,562 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Immedica Pharma US Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Dec 5, 2038 · High confidence

Filed Dec 5, 2018 as application 16/210,248 · Granted Aug 8, 2023
Base term, 20 years from filing
Today
20 years from filing
2018 2038
Clock starts
Dec 5, 2018
Term ends
Dec 5, 2038
Granted
Aug 8, 2023
base term Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 5, 2018, when this application, 16/210,248, was filedDec 5, 2038High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderDec 5, 2038High confidence

This family

US 11,717,562this patent
Dec 2038
Dec 2038
US 12,673,093In force
Jul 2039
Jul 2039
Application 19/698,353Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 10, 2019
Reel 47956, frame 209
Rowlinson, Scott W.; Quinn, Anthony G.Aerase, Inc.Assignment of Assignor's Interest
Jun 21, 2023
Reel 64012, frame 309
Lowe, David; Lowe, AnnAerase, Inc.Assignment of Assignor's Interest
Oct 2, 2023
Reel 65100, frame 963
Aeglea Biotherapeutics, Inc.; Aerase, Inc.Immedica Pharma ABAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited